Skip to main content
Glama

Entity Profile

entity_profile
Read-onlyIdempotent

"Tell me about X" / "research Acme" / "brief me on Tesla" / "what does Apple do" / "company profile for Microsoft" / "give me the rundown on NVDA" / "everything you know about $TICKER" — full cross-source profile of a US public company in ONE parallel call. ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view. Fans out across SEC EDGAR, XBRL, USPTO patents, federal contracts (USAspending), FDA-licensed biologics (Purple Book), H-1B hiring (DOL LCA), news and GLEIF, and returns: cik + company_name (+ resolved_from/resolved_to when value was a name); recent_filings (up to 5 with pipeworx://edgar/company/{cik}/filings/{accession} URIs); fundamentals (LATEST 10-K Revenues + NetIncomeLoss + Cash, sorted period_end DESC); patents (USPTO PatentsView API sunset May 2025 — soft-fails until reactivated); federal_contracts (USAspending awards where the company is the recipient); fda_products (FDA-licensed biologics — vaccines, cell/gene therapies — from the Purple Book; a company with only small-molecule/generic drugs will show none here, that is expected, not a failure); hiring (H-1B sponsorship volume + salary range from DOL LCA filings); recent news mentions via GDELT→GNews fallback; LEI via GLEIF. sources_used / sources_failed say which of these actually returned data for THIS company — an empty section is a real "no data", not a bug. Pass a ticker ("AAPL"), zero-padded CIK ("0000320193"), OR a company name ("Moderna") — names now resolve via SEC EDGAR's company-name match; a private company (no CIK/ticker) returns resolved:false with an explicit notes line, not a bare failure. type accepts "company" or "ticker" interchangeably — both take the same value shapes above.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYes"company" or "ticker" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon.
valueYesTicker (e.g., "AAPL"), zero-padded CIK (e.g., "0000320193"), or company name (e.g., "Moderna") — names resolve via SEC EDGAR company-name match.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. Only \"company\" supported today; person/place coming soon."New value: +"\"company\" or \"ticker\" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon."
    • changedInput schema / properties / type / enum
      Previous value: -[
      -  "company"
      -]New value: +[
      +  "company",
      +  "ticker"
      +]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker (e.g., \"AAPL\") or zero-padded CIK (e.g., \"0000320193\"). Names not supported — use resolve_entity first if you only have a name."New value: +"Ticker (e.g., \"AAPL\"), zero-padded CIK (e.g., \"0000320193\"), or company name (e.g., \"Moderna\") — names resolve via SEC EDGAR company-name match."
  2. First observed

TDQS

A4.8/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

The description goes well beyond the readOnly/openWorld/idempotent annotations by disclosing fan-out sources, soft-failure of the USPTO PatentsView API, expected empty results for companies without biologics, and the meaning of sources_used/sources_failed. It also explains the resolved:false behavior for private companies, which is valuable context not present in annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long but dense and front-loaded with the purpose and routing instruction before enumerating outputs. Some sentences are run-on, but nearly every clause carries useful information about sources, failure modes, or expected results, so the length is justified.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a complex multi-source tool with no output schema, the description covers inputs, output structure, source-specific caveats, empty-result semantics, and failure handling. An agent has enough context to decide when to call it and what to expect from the response.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

The schema already describes both parameters with 100% coverage, so the baseline is 3. The description adds extra clarity by stating that type accepts 'company' or 'ticker' interchangeably, and by explicitly enumerating ticker, zero-padded CIK, and company name as valid value forms with examples. This is useful reinforcement beyond the schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description leads with concrete user queries and states the core function: a 'full cross-source profile of a US public company in ONE parallel call.' It clearly distinguishes this from single-pack SEC/XBRL/news lookups, making the tool's scope and resource immediately identifiable.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It gives an explicit routing rule: 'ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view.' It also specifies the accepted input forms and the expected behavior for private companies, giving the agent clear conditions for when to call this tool.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.6/5.0
Disambiguation2/5

Several tools are near-indistinguishable by role: ask_pipeworx and ask_pipeworx_beta are documented as currently identical, and ask_pipeworx, ask_pipeworx_grounded, and deep_research overlap as lookup/research entry points. The six-tool Polymarket cluster and the suggest_questions/discover_tools pair add further boundary confusion despite very long descriptions.

Naming Consistency3/5

Snake_case is used consistently, and clusters like ask_pipeworx_* and polymarket_* have internal consistency. However, the global convention is mixed: verb_object names (get_cell, resolve_entity, unsubscribe) sit beside noun phrases (entity_profile, recent_changes, cells_in_area) and product-prefixed nouns (pipeworx_feedback, polymarket_edges), so tool names are not predictable from function.

Tool Count2/5

33 tools is too many for a server named Opencellid, especially since only get_cell and cells_in_area actually belong to the cell-tower domain. Even as a broader Pipeworx/data bundle, the set is heavy and includes unrelated one-offs like generate_llms_txt and scan_dependency.

Completeness2/5

For an OpenCellID server, the surface is just two lookups, missing coverage stats, operator-based search, and other natural cell-tower operations. If judged instead as a Pipeworx data-research suite, coverage is broad, but the lack of a coherent stated domain makes obvious gaps and dead ends harder to identify.